BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 7072691)

  • 1. Tissue carcinoembryonic antigen, dysplasia, and disease duration in colonic inflammatory bowel disease.
    Greenstein AJ; Panvelliwalla DK; Katz LB; Heimann TM; Donnelly J; Pertsimlidis D; Geller S; Smith H; Aufses AH
    Am J Gastroenterol; 1982 Apr; 77(4):212-5. PubMed ID: 7072691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical demonstration of carcinoembryonic antigen in normal, transitional and inflamed colonic mucosa.
    Wagener C; Hain F; Breuer H; Olude S; Cremer H; Müller-Wallraf R
    Oncodev Biol Med; 1981; 2(5):331-43. PubMed ID: 7036104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen (CEA). Use and limitations of the CEA radioimmunoassay in the diagnosis and follow-up of colo-rectal carcinoma.
    Mach JP; Pusztaszeri G; MacDonald D; Bertholet MM
    Johns Hopkins Med J Suppl; 1974; 3():369-79. PubMed ID: 4421371
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic studies in patients with Crohn disease and ulcerative colitis].
    Sauer H; Sauer D; Bendix U; Schumann B
    Allerg Immunol (Leipz); 1984; 30(1):23-33. PubMed ID: 6203390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinoembryonic antigen (CEA) test in ulcerative colitis and Crohn's disease. A prospective clinical investigation].
    Knudsen L; Siemssen O
    Ugeskr Laeger; 1975 Jul; 137(31):1775-8. PubMed ID: 1154524
    [No Abstract]   [Full Text] [Related]  

  • 7. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
    Maykel JA; Hagerman G; Mellgren AF; Li SY; Alavi K; Baxter NN; Madoff RD
    Dis Colon Rectum; 2006 Jul; 49(7):950-7. PubMed ID: 16729218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions.
    Shkolnik T; Livni E; Reshef R; Lachter J; Eidelman S
    Am J Gastroenterol; 1987 Dec; 82(12):1275-8. PubMed ID: 3318403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognosis of inflammatory bowel disease.
    Sales DJ; Kirsner JB
    Arch Intern Med; 1983 Feb; 143(2):294-9. PubMed ID: 6824395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of carcinoembryonic antigen in ulcerative colitis, tubular adenomas and hyperplastic polyps: correlations with the degree of dysplasia.
    Pavelic ZP; Pavelic L; Pavelic K; Genta RM; Ray MB; Dvornik G; Scukanec-Spoljar M; Peacock JS
    Anticancer Res; 1991; 11(5):1671-5. PubMed ID: 1768036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of elevation of serum carcinoembryonic antigen (CEA) levels in inflammatory diseases of the intestine.
    Booth SN; King JP; Leonard JC; Dykes PW
    Scand J Gastroenterol; 1974; 9(7):651-6. PubMed ID: 4428176
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's disease with adenocarcinoma and dysplasia. Macroscopical, histological, and immunohistochemical aspects of two cases.
    Cuvelier C; Bekaert E; De Potter C; Pauwels C; De Vos M; Roels H
    Am J Surg Pathol; 1989 Mar; 13(3):187-96. PubMed ID: 2465699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue demonstration of carcinoembryonic antigen (CEA) in ulcerative colitis.
    Isaacson P
    Gut; 1976 Jul; 17(7):561-7. PubMed ID: 964689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of colonic antigen(s) in tissues from ulcerative colitis using purified colitis colon tissue-bound IgG (CCA-IgG).
    Nagai T; Das KM
    Gastroenterology; 1981 Sep; 81(3):463-70. PubMed ID: 7018989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.
    Selby WS; Janossy G; Mason DY; Jewell DP
    Clin Exp Immunol; 1983 Sep; 53(3):614-8. PubMed ID: 6577996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
    Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
    Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carcinoembryonic antigen (CEA) levels and their clinical significance in Crohn's disease].
    Meryn S; Lochs H; Francesconi M
    Wien Klin Wochenschr; 1983 Apr; 95(9):301-4. PubMed ID: 6604368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.